A detailed history of Silver Coast Investments LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Silver Coast Investments LLC holds 10,657 shares of GILD stock, worth $882,612. This represents 0.3% of its overall portfolio holdings.

Number of Shares
10,657
Previous 8,870 20.15%
Holding current value
$882,612
Previous $650 Million 12.54%
% of portfolio
0.3%
Previous 0.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$63.15 - $72.88 $112,849 - $130,236
1,787 Added 20.15%
10,657 $731 Million
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $241,797 - $294,865
3,378 Added 61.51%
8,870 $650 Million
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $402,398 - $456,330
5,492 New
5,492 $445 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $104B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Silver Coast Investments LLC Portfolio

Follow Silver Coast Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silver Coast Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silver Coast Investments LLC with notifications on news.